Given that database analysis showed EMT and multi‐drug resistance enrichment in the CRC cohort with high HK2 expression, we hypothesized that HK2 simultaneously modulated EMT and chemoresistance in CRC, which has not yet been reported. Here, HK2 is linked to colorectal carcinoma.